Published in World Hosp Health Serv on January 01, 2006
ODYSSEE-vCHAT Pilot Trial for Heart Failure (ODYSSEE-vCHAT) | NCT04966104
Medical schools in sub-Saharan Africa. Lancet (2010) 8.85
Pilot study of an Internet patient-physician communication tool for heart failure disease management. J Med Internet Res (2005) 3.12
E-learning in medical education in resource constrained low- and middle-income countries. Hum Resour Health (2013) 2.85
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant (2010) 2.59
Compulsory service programmes for recruiting health workers in remote and rural areas: do they work? Bull World Health Organ (2010) 1.98
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ (2006) 1.73
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol (2004) 1.58
Physical activity patterns and exercise performance in cardiac transplant recipients. J Cardiopulm Rehabil (2003) 1.52
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol (2012) 1.44
Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction. Transplantation (2008) 1.44
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. J Heart Lung Transplant (2006) 1.42
Acute heart failure: perspectives from a randomized trial and a simultaneous registry. Circ Heart Fail (2012) 1.42
Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study. Can J Anaesth (2006) 1.25
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol (2005) 1.25
Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. Am J Physiol Heart Circ Physiol (2007) 1.21
Medical management to optimize donor organ potential: review of the literature. Can J Anaesth (2006) 1.17
An interactive Internet site for the management of patients with congestive heart failure. Can J Cardiol (2003) 1.14
Cardiac allograft vasculopathy: a review. Can J Surg (2005) 1.11
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
HIV infection in refugees: a case-control analysis of refugees in Rhode Island. Int J Infect Dis (2008) 1.03
Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy. Can J Cardiol (2009) 0.99
Comparing administration of questionnaires via the internet to pen-and-paper in patients with heart failure: randomized controlled trial. J Med Internet Res (2009) 0.96
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline. Transfus Med Rev (2010) 0.95
Organ utilization among deceased donors in Canada, 1993-2002. Can J Anaesth (2006) 0.92
2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. Can J Cardiol (2003) 0.90
The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol (2006) 0.89
Effect of global ischemia and reperfusion during ventricular fibrillation in myopathic human hearts. Am J Physiol Heart Circ Physiol (2009) 0.88
Modulation of fructokinase activity of potato (Solanum tuberosum) results in substantial shifts in tuber metabolism. Plant Cell Physiol (2005) 0.88
Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration. Int J Pharm (2009) 0.88
Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation (2016) 0.87
Renal transplant outcome in high-cardiovascular risk recipients. Clin Transplant (2007) 0.86
Determination of the action spectrum of the blue-light hazard for different intraocular lenses. J Opt Soc Am A Opt Image Sci Vis (2007) 0.86
HLA-G in organ transplantation: towards clinical applications. Cell Mol Life Sci (2010) 0.86
Lipid nanoparticles as drug/gene delivery systems to the retina. J Ocul Pharmacol Ther (2013) 0.85
An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol. JMIR Res Protoc (2014) 0.85
Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation. J Heart Lung Transplant (2006) 0.84
Surgical biology for the clinician: vascular effects of immunosuppression. Can J Surg (2010) 0.84
Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung Transplant (2008) 0.84
Optimizing the immunosuppressive regimen in heart transplantation. J Heart Lung Transplant (2004) 0.83
Caring for HIV-infected refugees in Rhode Island. Med Health R I (2007) 0.83
Permanent pacing after cardiac transplantation in the era of extended donors. J Heart Lung Transplant (2006) 0.83
Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Circulation (2006) 0.83
Three-Dimensional Platelet-Rich Plasma Hydrogel Model to Study Early Tendon Healing. Cells Tissues Organs (2015) 0.83
Strawberry polyphenols are equally cytotoxic to tumourigenic and normal human breast and prostate cell lines. Int J Oncol (2009) 0.81
Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides. Recent Pat Drug Deliv Formul (2011) 0.81
Rate and predictors of the conversion of abstracts presented at the Canadian Cardiovascular Congress scientific meetings to full peer-reviewed publications. Can J Cardiol (2013) 0.80
Usability Testing of an Internet-Based e-Counseling Platform for Adults With Chronic Heart Failure. JMIR Hum Factors (2015) 0.80
Animal spare parts? A Canadian public consultation on xenotransplantation. Sci Eng Ethics (2002) 0.80
A prospective examination of disease management program use by complex cardiac outpatients. Can J Cardiol (2012) 0.80
The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant (2011) 0.79
Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients. Transpl Int (2010) 0.79
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation. Transplantation (2011) 0.79
Development of a practice tool for community-based nurses: the Heart Failure Palliative Approach to Care (HeFPAC). Eur J Cardiovasc Nurs (2014) 0.79
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. Transplantation (2006) 0.79
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. J Heart Lung Transplant (2005) 0.79
Evaluation of a web-based interactive heart failure patient simulation: a pilot study. Can J Cardiol (2011) 0.78
Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients. Clin Transplant (2007) 0.78
Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions. Circ Heart Fail (2012) 0.78
Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunction. Transplantation (2005) 0.77
Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial. J Transplant (2011) 0.77
Factors related to participation in paid work after organ transplantation: perceptions of kidney transplant recipients. J Occup Rehabil (2015) 0.77
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts. Immunology (2015) 0.76
Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy. Drug Des Devel Ther (2012) 0.76
Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods. Control Clin Trials (2003) 0.76
Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine. J Heart Lung Transplant (2013) 0.76
Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant (2006) 0.76
Images in cardiovascular medicine. Alfieri mitral valve repair: clinical outcome and pathology. Circulation (2002) 0.76
Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias. Int J Cardiovasc Imaging (2013) 0.76
Morphological changes in porcine bioprosthetic valves of a HeartMate left ventricular assist device. Can J Cardiol (2010) 0.75
Preparation and Support of Patients through the Transplant Process: Understanding the Recipients' Perspectives. Nurs Res Pract (2012) 0.75
Constrictive pericarditis after cardiac transplantation. J Heart Lung Transplant (2009) 0.75
The effectiveness of renal transplantation as a treatment for recurrent uremic cardiomyopathy. Can J Cardiol (2008) 0.75
Medical Education in Decentralized Settings: How Medical Students Contribute to Health Care in 10 Sub-Saharan African Countries. Acad Med (2017) 0.75
Integrating research and education into clinical practice: the multi-organ transplant student research training program. Healthc Manage Forum (2012) 0.75
Decade of HIV in Rhode Island: demographic and clinical characteristics of patients diagnosed in 2001 and 2010. R I Med J (2013) (2013) 0.75
Synthesis of ceramic nanoparticles by ultrafast laser ablation of solid targets in water. J Nanosci Nanotechnol (2006) 0.75
Canadian Consensus on cardiac transplantation in pediatric and adult congenital heart disease patients 2004: executive summary. Can J Cardiol (2005) 0.75
Distinct Patterns of Hyperpnea During Cheyne-Stokes Respiration: Implication for Cardiac Function in Patients With Heart Failure. J Clin Sleep Med (2017) 0.75
An unappetizing dog bone: cardiac sarcoidosis presenting with heart block and unusual left ventricular bulging. Eur Heart J (2007) 0.75
Non-linear Young's double-slit experiment. Opt Express (2006) 0.75
Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart. Can J Cardiol (2004) 0.75
Predictors of Survival and Favorable Neurologic Outcome in Patients Treated with eCPR: a Systematic Review and Meta-analysis. J Cardiovasc Transl Res (2022) 0.75
Strength through leadership, knowledge and community. Can J Cardiol (2014) 0.75
Valve-sparing root and ascending aorta replacement after heart transplantation. Ann Thorac Surg (2012) 0.75
A cardiac and a kidney transplant patient above 6000 meters in Bolivia. Wilderness Environ Med (2009) 0.75
Persistent elevation of VEGF and prostacyclin following poor cardiopulmonary adaptation to high altitude. Wilderness Environ Med (2009) 0.75
Experimental biomarkers in heart failure: an update. Expert Rev Cardiovasc Ther (2012) 0.75
Who needs a transplant and when? Curr Opin Organ Transplant (2012) 0.75
Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant. Ann Pharmacother (2009) 0.75
Early morphological changes of an Amplatzer Septal Occluder explanted at heart transplant. Cardiovasc Pathol (2007) 0.75
Concepts and a methodology for evaluating environmental services from trees of small farms in Chiapas, México. J Environ Manage (2012) 0.75